IL-17A antagonists

Details for Australian Patent Application No. 2010313304 (hide)

Owner Janssen Biotech, Inc.

Inventors Naso, Michael; Sweet, Raymond; Luo, Jinquan; Wu, Sheng-Jiun; Elloso, Merle; Ducata, Daniela Della; Rauchenberger, Robert; Rutz, Mark; Almagro, Juan Carlos; Taudte, Susann; Wu, Bingyuan; Obmolova, Galina; Malia, Thomas

Agent Shelston IP

Pub. Number AU-A-2010313304

PCT Pub. Number WO2011/053763

Priority 61/310,919 05.03.10 US; 61/256,862 30.10.09 US

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/053763 Priority application(s): WO2011/053763

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313308-Extended length and higher density packages of bulky yarns and methods of making the same

2010313299-Method of detaching a muscle and beef products produced by the method